Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

Fig. 1

FIRE-8 Study Design. Legend: mCRC, metastatic colorectal cancer; R, randomization; BSA, body surface area; BID, twice daily; BW, body weight. Microsoft PowerPoint version 16.62 was used to generate this figure

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us